"title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","characteristics_ch1.8","characteristics_ch1.9","characteristics_ch1.10","characteristics_ch1.11","characteristics_ch1.12","characteristics_ch1.13","characteristics_ch1.14","characteristics_ch1.15","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","adjuvant_chemotherapy:ch1","age at diagnosis:ch1","event_death:ch1","event_metastasis:ch1","follow_up_duration (years):ch1","gender:ch1","m_stage:ch1","n_stage:ch1","neoadjuvant chemotherapy:ch1","regimen (caf vs cmf):ch1","regional_relapse:ch1","subtype:ch1","t_stage:ch1","time_to_metastasis (years):ch1","time_to_relapse (years):ch1","tissue:ch1"
"GSM519117","BRC001","GSM519117","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 33","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC001","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519117/suppl/GSM519117.CEL.gz","54627","yes","33","0","0","7","female","0","2",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519118","BRC002","GSM519118","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 7.4","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC002","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519118/suppl/GSM519118.CEL.gz","54627","yes","40","0","0","7.4","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519119","BRC003","GSM519119","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 35","event_death: 0","follow_up_duration (years): 7.2","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC003","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519119/suppl/GSM519119.CEL.gz","54627","yes","35","0","0","7.2","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519120","BRC004","GSM519120","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 6.3","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC004","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519120/suppl/GSM519120.CEL.gz","54627","yes","47","0","0","6.3","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519121","BRC005","GSM519121","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC005","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519121/suppl/GSM519121.CEL.gz","54627","yes","41","0","0","7","female","0","2",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519122","BRC006","GSM519122","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 7.3","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC006","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519122/suppl/GSM519122.CEL.gz","54627","yes","44","0","0","7.3","female","0","3",NA,"others","0","type II","2",NA,NA,"primary breast cancer"
"GSM519123","BRC007","GSM519123","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 6.8","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC007","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519123/suppl/GSM519123.CEL.gz","54627","no","62","0","0","6.8","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519124","BRC008","GSM519124","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 7.1","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC008","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519124/suppl/GSM519124.CEL.gz","54627","yes","43","0","0","7.1","female","0","1",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519125","BRC009","GSM519125","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC009","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519125/suppl/GSM519125.CEL.gz","54627","yes","40","0","0","6.5","female","0","2",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519126","BRC010","GSM519126","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 1","follow_up_duration (years): 5.4","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 3.5","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC010","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519126/suppl/GSM519126.CEL.gz","54627","yes","48","1","0","5.4","female","0","1",NA,"others","1","type I","2",NA,"3.5","primary breast cancer"
"GSM519127","BRC011","GSM519127","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 33","event_death: 0","follow_up_duration (years): 7.1","event_metastasis: 0","subtype: type III","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC011","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519127/suppl/GSM519127.CEL.gz","54627","yes","33","0","0","7.1","female","0","3",NA,"others","0","type III","3",NA,NA,"primary breast cancer"
"GSM519128","BRC012","GSM519128","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 6.9","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC012","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519128/suppl/GSM519128.CEL.gz","54627","yes","51","0","0","6.9","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519129","BRC013","GSM519129","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC013","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519129/suppl/GSM519129.CEL.gz","54627","yes","57","0","0","7","female","0","0",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519130","BRC014","GSM519130","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC014","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519130/suppl/GSM519130.CEL.gz","54627","yes","43","0","0","6.4","female","0","0",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519131","BRC015","GSM519131","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC015","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519131/suppl/GSM519131.CEL.gz","54627","yes","38","0","0","7","female","0","0",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519132","BRC016","GSM519132","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 8","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC016","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519132/suppl/GSM519132.CEL.gz","54627","no","48","0","0","8","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519133","BRC017","GSM519133","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 1","follow_up_duration (years): 1.8","event_metastasis: 1","time_to_metastasis (years): 1.6","subtype: type II","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.1","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC017","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519133/suppl/GSM519133.CEL.gz","54627","yes","41","1","1","1.8","female","0","3","yes","others","1","type II","2","1.6","1.1","primary breast cancer"
"GSM519134","BRC018","GSM519134","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 6.1","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC018","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519134/suppl/GSM519134.CEL.gz","54627","yes","39","0","0","6.1","female","0","1",NA,"CAF","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519135","BRC019","GSM519135","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 1","follow_up_duration (years): 3.5","event_metastasis: 1","time_to_metastasis (years): 1.7","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC019","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519135/suppl/GSM519135.CEL.gz","54627","yes","63","1","1","3.5","female","0","2",NA,"others","0","type II","2","1.7",NA,"primary breast cancer"
"GSM519136","BRC020","GSM519136","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 7","event_metastasis: 1","time_to_metastasis (years): 5.1","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC020","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519136/suppl/GSM519136.CEL.gz","54627","yes","43","0","1","7","female","0","0",NA,"others","NA","type IV","2","5.1",NA,"primary breast cancer"
"GSM519137","BRC021","GSM519137","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 7.2","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC021","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519137/suppl/GSM519137.CEL.gz","54627","yes","55","0","0","7.2","female","0","0",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519138","BRC022","GSM519138","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 25","event_death: 1","follow_up_duration (years): 5.2","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type IV","t_stage: 4","n_stage: 3","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC022","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519138/suppl/GSM519138.CEL.gz","54627","yes","25","1","1","5.2","female","1","3","yes","others","0","type IV","4","0",NA,"primary breast cancer"
"GSM519139","BRC023","GSM519139","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 7.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC023","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519139/suppl/GSM519139.CEL.gz","54627","yes","45","0","0","7.1","female","0","2",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519140","BRC024","GSM519140","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 6.8","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC024","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519140/suppl/GSM519140.CEL.gz","54627","yes","45","0","0","6.8","female","0","1",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519141","BRC025","GSM519141","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 1","follow_up_duration (years): 1.9","event_metastasis: 1","time_to_metastasis (years): 1.4","subtype: type IV","t_stage: 3","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC025","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519141/suppl/GSM519141.CEL.gz","54627","yes","62","1","1","1.9","female","0","1","yes","others","0","type IV","3","1.4",NA,"primary breast cancer"
"GSM519142","BRC026","GSM519142","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 6.9","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC026","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519142/suppl/GSM519142.CEL.gz","54627","yes","43","0","0","6.9","female","0","0",NA,"CMF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519143","BRC027","GSM519143","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 66","event_death: 0","follow_up_duration (years): 5.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: unknown","regimen (caf vs cmf): unknown","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC027","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519143/suppl/GSM519143.CEL.gz","54627","unknown","66","0","0","5.4","female","0","1",NA,"unknown","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519144","BRC028","GSM519144","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 1","follow_up_duration (years): 1.2","event_metastasis: 1","time_to_metastasis (years): 0.8","subtype: type I","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC028","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519144/suppl/GSM519144.CEL.gz","54627","yes","42","1","1","1.2","female","0","3",NA,"others","0","type I","2","0.8",NA,"primary breast cancer"
"GSM519145","BRC029","GSM519145","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 1","follow_up_duration (years): 5.8","event_metastasis: 1","time_to_metastasis (years): 5.7","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC029","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519145/suppl/GSM519145.CEL.gz","54627","yes","44","1","1","5.8","female","0","0",NA,"others","0","type IV","1","5.7",NA,"primary breast cancer"
"GSM519146","BRC030","GSM519146","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 6.9","event_metastasis: 1","time_to_metastasis (years): 4.1","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC030","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519146/suppl/GSM519146.CEL.gz","54627","yes","39","0","1","6.9","female","0","1",NA,"others","0","type VI","2","4.1",NA,"primary breast cancer"
"GSM519147","BRC031","GSM519147","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC031","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519147/suppl/GSM519147.CEL.gz","54627","yes","52","0","0","6.5","female","0","1",NA,"others","0","type V","2",NA,NA,"primary breast cancer"
"GSM519148","BRC032","GSM519148","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 0","follow_up_duration (years): 6.9","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC032","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519148/suppl/GSM519148.CEL.gz","54627","yes","63","0","0","6.9","female","0","1",NA,"others","0","type V","1",NA,NA,"primary breast cancer"
"GSM519149","BRC033","GSM519149","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 35","event_death: 1","follow_up_duration (years): 4","event_metastasis: 1","time_to_metastasis (years): 2.6","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 2.3","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC033","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519149/suppl/GSM519149.CEL.gz","54627","yes","35","1","1","4","female","0","0",NA,"CMF","1","type IV","2","2.6","2.3","primary breast cancer"
"GSM519150","BRC034","GSM519150","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 6.7","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC034","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519150/suppl/GSM519150.CEL.gz","54627","yes","43","0","0","6.7","female","0","0",NA,"others","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519151","BRC035","GSM519151","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 6","event_metastasis: 0","subtype: type I","t_stage: 1c","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC035","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519151/suppl/GSM519151.CEL.gz","54627","yes","47","0","0","6","female","0","0",NA,"CMF","0","type I","1c",NA,NA,"primary breast cancer"
"GSM519152","BRC036","GSM519152","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 31","event_death: 0","follow_up_duration (years): 6","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC036","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519152/suppl/GSM519152.CEL.gz","54627","yes","31","0","0","6","female","0","0",NA,"others","NA","type I","2",NA,NA,"primary breast cancer"
"GSM519153","BRC037","GSM519153","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 29","event_death: 1","follow_up_duration (years): 3.7","event_metastasis: 1","time_to_metastasis (years): 3","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC037","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519153/suppl/GSM519153.CEL.gz","54627","yes","29","1","1","3.7","female","0","1",NA,"others","0","type IV","2","3",NA,"primary breast cancer"
"GSM519154","BRC038","GSM519154","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 1","follow_up_duration (years): 0.8","event_metastasis: 1","time_to_metastasis (years): 0.7","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 0.6","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC038","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519154/suppl/GSM519154.CEL.gz","54627","yes","58","1","1","0.8","female","0","2",NA,"others","1","type II","2","0.7","0.6","primary breast cancer"
"GSM519155","BRC039","GSM519155","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 6.7","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC039","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519155/suppl/GSM519155.CEL.gz","54627","yes","46","0","0","6.7","female","0","0",NA,"others","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519156","BRC040","GSM519156","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 67","event_death: 0","follow_up_duration (years): 5.8","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC040","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519156/suppl/GSM519156.CEL.gz","54627","yes","67","0","0","5.8","female","0","0",NA,"others","0","type V","2",NA,NA,"primary breast cancer"
"GSM519157","BRC041","GSM519157","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 6","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC041","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519157/suppl/GSM519157.CEL.gz","54627","yes","43","0","0","6","female","0","0",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519158","BRC042","GSM519158","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 6.3","event_metastasis: 0","subtype: type II","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC042","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519158/suppl/GSM519158.CEL.gz","54627","yes","46","0","0","6.3","female","0","0",NA,"others","0","type II","1",NA,NA,"primary breast cancer"
"GSM519159","BRC043","GSM519159","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 33","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC043","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519159/suppl/GSM519159.CEL.gz","54627","yes","33","0","0","6.4","female","0","1",NA,"others","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519160","BRC044","GSM519160","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 5.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC044","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519160/suppl/GSM519160.CEL.gz","54627","yes","38","0","0","5.1","female","0","3",NA,"others","0","type V","1",NA,NA,"primary breast cancer"
"GSM519161","BRC045","GSM519161","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC045","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519161/suppl/GSM519161.CEL.gz","54627","yes","48","0","0","6.4","female","0","1",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519162","BRC046","GSM519162","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 5.9","event_metastasis: 0","subtype: type IV","t_stage: 3","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC046","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519162/suppl/GSM519162.CEL.gz","54627","yes","49","0","0","5.9","female","0","0",NA,"others","0","type IV","3",NA,NA,"primary breast cancer"
"GSM519163","BRC047","GSM519163","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 5.4","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC047","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519163/suppl/GSM519163.CEL.gz","54627","yes","52","0","0","5.4","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519164","BRC048","GSM519164","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 66","event_death: 0","follow_up_duration (years): 5.9","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC048","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519164/suppl/GSM519164.CEL.gz","54627","yes","66","0","0","5.9","female","0","0",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519165","BRC049","GSM519165","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC049","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519165/suppl/GSM519165.CEL.gz","54627","yes","49","0","0","6.4","female","0","1",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519166","BRC050","GSM519166","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 1","follow_up_duration (years): 2.3","event_metastasis: 1","time_to_metastasis (years): 1.2","subtype: type IV","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.2","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC050","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519166/suppl/GSM519166.CEL.gz","54627","yes","53","1","1","2.3","female","0","3","yes","others","1","type IV","3","1.2","1.2","primary breast cancer"
"GSM519167","BRC051","GSM519167","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC051","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519167/suppl/GSM519167.CEL.gz","54627","yes","41","0","0","7","female","0","0",NA,"CAF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519168","BRC052","GSM519168","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC052","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519168/suppl/GSM519168.CEL.gz","54627","yes","40","0","0","6.5","female","0","3",NA,"others","0","type VI","3",NA,NA,"primary breast cancer"
"GSM519169","BRC053","GSM519169","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 67","event_death: 0","follow_up_duration (years): 6","event_metastasis: 0","subtype: type V","t_stage: 1c","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC053","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519169/suppl/GSM519169.CEL.gz","54627","yes","67","0","0","6","female","0","0",NA,"CMF","0","type V","1c",NA,NA,"primary breast cancer"
"GSM519170","BRC054","GSM519170","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 60","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC054","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519170/suppl/GSM519170.CEL.gz","54627","yes","60","0","0","6.5","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519171","BRC055","GSM519171","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 6.9","event_metastasis: 0","subtype: type III","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC055","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519171/suppl/GSM519171.CEL.gz","54627","yes","48","0","0","6.9","female","0","3","yes","others","0","type III","3",NA,NA,"primary breast cancer"
"GSM519172","BRC056","GSM519172","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 1","follow_up_duration (years): 1.8","event_metastasis: 1","time_to_metastasis (years): 1.6","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC056","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519172/suppl/GSM519172.CEL.gz","54627","yes","55","1","1","1.8","female","0","1",NA,"CAF","0","type II","2","1.6",NA,"primary breast cancer"
"GSM519173","BRC057","GSM519173","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 68","event_death: 0","follow_up_duration (years): 6.8","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC057","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519173/suppl/GSM519173.CEL.gz","54627","yes","68","0","0","6.8","female","0","2",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519174","BRC058","GSM519174","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 68","event_death: 0","follow_up_duration (years): 6.8","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC058","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519174/suppl/GSM519174.CEL.gz","54627","yes","68","0","0","6.8","female","0","0",NA,"others","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519175","BRC059","GSM519175","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 61","event_death: 0","follow_up_duration (years): 5.3","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC059","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519175/suppl/GSM519175.CEL.gz","54627","yes","61","0","0","5.3","female","0","3",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519176","BRC060","GSM519176","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 61","event_death: 0","follow_up_duration (years): 5.7","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC060","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519176/suppl/GSM519176.CEL.gz","54627","yes","61","0","0","5.7","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519177","BRC061","GSM519177","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 24","event_death: 0","follow_up_duration (years): 6.6","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC061","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519177/suppl/GSM519177.CEL.gz","54627","yes","24","0","0","6.6","female","0","0",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519178","BRC062","GSM519178","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 5.2","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC062","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519178/suppl/GSM519178.CEL.gz","54627","yes","45","0","0","5.2","female","0","0",NA,"CMF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519179","BRC063","GSM519179","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 4.9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC063","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519179/suppl/GSM519179.CEL.gz","54627","yes","49","0","0","4.9","female","0","0",NA,"CMF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519180","BRC064","GSM519180","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 0","follow_up_duration (years): 5.1","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC064","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519180/suppl/GSM519180.CEL.gz","54627","yes","34","0","0","5.1","female","0","1",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519181","BRC065","GSM519181","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 61","event_death: 0","follow_up_duration (years): 6.1","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC065","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519181/suppl/GSM519181.CEL.gz","54627","yes","61","0","0","6.1","female","0","1",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519182","BRC066","GSM519182","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 9.2","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC066","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519182/suppl/GSM519182.CEL.gz","54627","yes","45","0","0","9.2","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519183","BRC067","GSM519183","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC067","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519183/suppl/GSM519183.CEL.gz","54627","yes","54","0","0","6.5","female","0","0",NA,"CAF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519184","BRC068","GSM519184","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 5","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC068","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519184/suppl/GSM519184.CEL.gz","54627","yes","62","0","0","5","female","0","0",NA,"CMF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519185","BRC069","GSM519185","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 6.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC069","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519185/suppl/GSM519185.CEL.gz","54627","yes","47","0","0","6.1","female","0","0",NA,"CAF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519186","BRC070","GSM519186","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 6.6","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC070","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519186/suppl/GSM519186.CEL.gz","54627","yes","43","0","0","6.6","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519187","BRC071","GSM519187","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 70","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC071","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519187/suppl/GSM519187.CEL.gz","54627","yes","70","0","0","6.5","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519188","BRC072","GSM519188","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 0","follow_up_duration (years): 6.8","event_metastasis: 0","subtype: type III","t_stage: 4","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC072","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519188/suppl/GSM519188.CEL.gz","54627","yes","42","0","0","6.8","female","0","0","yes","others","0","type III","4",NA,NA,"primary breast cancer"
"GSM519189","BRC073","GSM519189","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC073","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519189/suppl/GSM519189.CEL.gz","54627","yes","48","0","0","6.4","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519190","BRC074","GSM519190","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 60","event_death: 1","follow_up_duration (years): 0.9","event_metastasis: 0","subtype: type II","t_stage: 4","n_stage: 2","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC074","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519190/suppl/GSM519190.CEL.gz","54627","yes","60","1","0","0.9","female","0","2","yes","others","NA","type II","4",NA,NA,"primary breast cancer"
"GSM519191","BRC075","GSM519191","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 59","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC075","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519191/suppl/GSM519191.CEL.gz","54627","yes","59","0","0","6.4","female","0","0",NA,"CAF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519192","BRC076","GSM519192","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC076","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519192/suppl/GSM519192.CEL.gz","54627","yes","50","0","0","6.5","female","0","0",NA,"CAF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519193","BRC077","GSM519193","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 4","event_metastasis: 1","time_to_metastasis (years): 2.1","subtype: type II","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC077","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519193/suppl/GSM519193.CEL.gz","54627","yes","46","1","1","4","female","0","1",NA,"CMF","0","type II","1","2.1",NA,"primary breast cancer"
"GSM519194","BRC078","GSM519194","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 10.6","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC078","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519194/suppl/GSM519194.CEL.gz","54627","yes","38","0","0","10.6","female","0","1",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519195","BRC079","GSM519195","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 1","follow_up_duration (years): 14.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC079","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519195/suppl/GSM519195.CEL.gz","54627","no","58","1","0","14.1","female","0","2",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519196","BRC080","GSM519196","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 1","follow_up_duration (years): 2.3","event_metastasis: 0","subtype: type II","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC080","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519196/suppl/GSM519196.CEL.gz","54627","yes","42","1","0","2.3","female","0","2",NA,"others","NA","type II","3",NA,NA,"primary breast cancer"
"GSM519197","BRC081","GSM519197","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 13.8","event_metastasis: 1","time_to_metastasis (years): 8.2","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 7.2","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC081","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519197/suppl/GSM519197.CEL.gz","54627","yes","51","0","1","13.8","female","0","1",NA,"CMF","1","type II","2","8.2","7.2","primary breast cancer"
"GSM519198","BRC082","GSM519198","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 13.8","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC082","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519198/suppl/GSM519198.CEL.gz","54627","yes","53","0","0","13.8","female","0","2",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519199","BRC083","GSM519199","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 14.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC083","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519199/suppl/GSM519199.CEL.gz","54627","yes","40","0","0","14.1","female","0","0",NA,"CMF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519200","BRC084","GSM519200","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 1","follow_up_duration (years): 4.3","event_metastasis: 1","time_to_metastasis (years): 2.9","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC084","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519200/suppl/GSM519200.CEL.gz","54627","yes","52","1","1","4.3","female","0","2",NA,"CMF","NA","type IV","2","2.9",NA,"primary breast cancer"
"GSM519201","BRC085","GSM519201","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 13.2","event_metastasis: 0","subtype: type II","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC085","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519201/suppl/GSM519201.CEL.gz","54627","yes","57","0","0","13.2","female","0","1",NA,"CMF","0","type II","1",NA,NA,"primary breast cancer"
"GSM519202","BRC086","GSM519202","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 1","follow_up_duration (years): 4.7","event_metastasis: 1","time_to_metastasis (years): 2.4","subtype: type IV","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC086","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519202/suppl/GSM519202.CEL.gz","54627","yes","40","1","1","4.7","female","0","3",NA,"others","0","type IV","3","2.4",NA,"primary breast cancer"
"GSM519203","BRC087","GSM519203","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 1","follow_up_duration (years): 9","event_metastasis: 1","time_to_metastasis (years): 3.5","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC087","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519203/suppl/GSM519203.CEL.gz","54627","no","39","1","1","9","female","0","0",NA,"no","0","type IV","1","3.5",NA,"primary breast cancer"
"GSM519204","BRC088","GSM519204","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 1","follow_up_duration (years): 2.9","event_metastasis: 1","time_to_metastasis (years): 1.6","subtype: type II","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC088","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519204/suppl/GSM519204.CEL.gz","54627","yes","44","1","1","2.9","female","0","3",NA,"others","0","type II","2","1.6",NA,"primary breast cancer"
"GSM519205","BRC089","GSM519205","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 11.6","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC089","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519205/suppl/GSM519205.CEL.gz","54627","no","39","0","0","11.6","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519206","BRC090","GSM519206","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 27","event_death: 0","follow_up_duration (years): 11.5","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC090","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519206/suppl/GSM519206.CEL.gz","54627","yes","27","0","0","11.5","female","0","0",NA,"CMF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519207","BRC091","GSM519207","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 13","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC091","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519207/suppl/GSM519207.CEL.gz","54627","yes","54","0","0","13","female","0","3",NA,"CMF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519208","BRC092","GSM519208","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 0","follow_up_duration (years): 13.1","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC092","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519208/suppl/GSM519208.CEL.gz","54627","yes","34","0","0","13.1","female","0","1",NA,"CMF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519209","BRC093","GSM519209","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 12.4","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 11.2","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC093","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519209/suppl/GSM519209.CEL.gz","54627","no","48","0","0","12.4","female","0","0",NA,"no","1","type VI","2",NA,"11.2","primary breast cancer"
"GSM519210","BRC094","GSM519210","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 1","follow_up_duration (years): 0.8","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC094","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519210/suppl/GSM519210.CEL.gz","54627","no","53","1","0","0.8","female","0","0",NA,"no","0","type III","1",NA,NA,"primary breast cancer"
"GSM519211","BRC095","GSM519211","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 11.6","event_metastasis: 0","subtype: type IV","t_stage: 3","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC095","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519211/suppl/GSM519211.CEL.gz","54627","yes","41","0","0","11.6","female","0","0",NA,"CMF","0","type IV","3",NA,NA,"primary breast cancer"
"GSM519212","BRC096","GSM519212","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 1","follow_up_duration (years): 6.3","event_metastasis: 1","time_to_metastasis (years): 4.8","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC096","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519212/suppl/GSM519212.CEL.gz","54627","yes","40","1","1","6.3","female","0","2",NA,"others","0","type VI","2","4.8",NA,"primary breast cancer"
"GSM519213","BRC097","GSM519213","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 1","follow_up_duration (years): 4.9","event_metastasis: 1","time_to_metastasis (years): 3.8","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC097","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519213/suppl/GSM519213.CEL.gz","54627","yes","38","1","1","4.9","female","0","1","yes","others","0","type IV","2","3.8",NA,"primary breast cancer"
"GSM519214","BRC098","GSM519214","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 71","event_death: 1","follow_up_duration (years): 8.3","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC098","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519214/suppl/GSM519214.CEL.gz","54627","no","71","1","0","8.3","female","0","1",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519215","BRC099","GSM519215","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 0","follow_up_duration (years): 13.3","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC099","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519215/suppl/GSM519215.CEL.gz","54627","yes","37","0","0","13.3","female","0","0",NA,"CMF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519216","BRC100","GSM519216","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 12.2","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC100","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519216/suppl/GSM519216.CEL.gz","54627","yes","43","0","0","12.2","female","0","1",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519217","BRC101","GSM519217","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 1","follow_up_duration (years): 1.3","event_metastasis: 1","time_to_metastasis (years): 0.9","subtype: type I","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC101","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519217/suppl/GSM519217.CEL.gz","54627","yes","51","1","1","1.3","female","0","3",NA,"others","NA","type I","2","0.9",NA,"primary breast cancer"
"GSM519218","BRC102","GSM519218","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 12.2","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC102","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519218/suppl/GSM519218.CEL.gz","54627","yes","39","0","0","12.2","female","0","0",NA,"CMF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519219","BRC103","GSM519219","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 77","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC103","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519219/suppl/GSM519219.CEL.gz","54627","no","77","0","0","8.1","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519220","BRC104","GSM519220","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC104","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519220/suppl/GSM519220.CEL.gz","54627","yes","43","0","0","11","female","0","0",NA,"CMF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519221","BRC105","GSM519221","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 12.2","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC105","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519221/suppl/GSM519221.CEL.gz","54627","yes","38","0","0","12.2","female","0","2",NA,"others","0","type V","2",NA,NA,"primary breast cancer"
"GSM519222","BRC106","GSM519222","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 36","event_death: 1","follow_up_duration (years): 5","event_metastasis: 1","time_to_metastasis (years): 3.6","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC106","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519222/suppl/GSM519222.CEL.gz","54627","yes","36","1","1","5","female","0","1",NA,"CMF","0","type IV","2","3.6",NA,"primary breast cancer"
"GSM519223","BRC107","GSM519223","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 1","follow_up_duration (years): 1.4","event_metastasis: 1","time_to_metastasis (years): 0.5","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC107","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519223/suppl/GSM519223.CEL.gz","54627","yes","62","1","1","1.4","female","0","2",NA,"CMF","0","type IV","2","0.5",NA,"primary breast cancer"
"GSM519224","BRC108","GSM519224","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 1","follow_up_duration (years): 6.5","event_metastasis: 1","time_to_metastasis (years): 5.9","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 4.3","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC108","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519224/suppl/GSM519224.CEL.gz","54627","yes","43","1","1","6.5","female","0","0",NA,"CMF","1","type VI","1","5.9","4.3","primary breast cancer"
"GSM519225","BRC109","GSM519225","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 61","event_death: 1","follow_up_duration (years): 5.7","event_metastasis: 1","time_to_metastasis (years): 4","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC109","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519225/suppl/GSM519225.CEL.gz","54627","yes","61","1","1","5.7","female","0","2",NA,"others","0","type IV","2","4",NA,"primary breast cancer"
"GSM519226","BRC110","GSM519226","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 0","follow_up_duration (years): 9.8","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC110","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519226/suppl/GSM519226.CEL.gz","54627","no","63","0","0","9.8","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519227","BRC111","GSM519227","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 11.6","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC111","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519227/suppl/GSM519227.CEL.gz","54627","no","52","0","0","11.6","female","0","1",NA,"no","0","type V","2",NA,NA,"primary breast cancer"
"GSM519228","BRC112","GSM519228","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 12.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC112","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519228/suppl/GSM519228.CEL.gz","54627","no","47","0","0","12.1","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519229","BRC113","GSM519229","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 1","follow_up_duration (years): 9.2","event_metastasis: 1","time_to_metastasis (years): 2.7","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC113","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519229/suppl/GSM519229.CEL.gz","54627","no","50","1","1","9.2","female","0","1",NA,"no","0","type VI","2","2.7",NA,"primary breast cancer"
"GSM519230","BRC114","GSM519230","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 12.9","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC114","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519230/suppl/GSM519230.CEL.gz","54627","yes","48","0","0","12.9","female","0","0",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519231","BRC115","GSM519231","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 32","event_death: 0","follow_up_duration (years): 12.7","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC115","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519231/suppl/GSM519231.CEL.gz","54627","yes","32","0","0","12.7","female","0","2",NA,"others","0","type II","2",NA,NA,"primary breast cancer"
"GSM519232","BRC116","GSM519232","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 12.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC116","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519232/suppl/GSM519232.CEL.gz","54627","yes","43","0","0","12.1","female","0","1",NA,"CMF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519233","BRC117","GSM519233","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 12.8","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC117","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519233/suppl/GSM519233.CEL.gz","54627","yes","51","0","0","12.8","female","0","0",NA,"CMF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519234","BRC118","GSM519234","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 59","event_death: 0","follow_up_duration (years): 10.9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC118","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519234/suppl/GSM519234.CEL.gz","54627","no","59","0","0","10.9","female","0","0",NA,"no","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519235","BRC119","GSM519235","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 1","follow_up_duration (years): 2.5","event_metastasis: 1","time_to_metastasis (years): 2.1","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC119","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519235/suppl/GSM519235.CEL.gz","54627","yes","40","1","1","2.5","female","0","2",NA,"others","0","type II","2","2.1",NA,"primary breast cancer"
"GSM519236","BRC120","GSM519236","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 1","follow_up_duration (years): 2","event_metastasis: 1","time_to_metastasis (years): 1.7","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC120","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519236/suppl/GSM519236.CEL.gz","54627","yes","43","1","1","2","female","0","2","yes","others","0","type VI","2","1.7",NA,"primary breast cancer"
"GSM519237","BRC121","GSM519237","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 1","follow_up_duration (years): 1.2","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type I","t_stage: 3","n_stage: 2","m_stage: 1","regional_relapse: 1","time_to_relapse (years): 0.7","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC121","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519237/suppl/GSM519237.CEL.gz","54627","yes","39","1","1","1.2","female","1","2","yes","others","1","type I","3","0","0.7","primary breast cancer"
"GSM519238","BRC122","GSM519238","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 1","follow_up_duration (years): 11.4","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type IV","t_stage: 4","n_stage: 2","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC122","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519238/suppl/GSM519238.CEL.gz","54627","no","43","1","1","11.4","female","1","2",NA,"no","0","type IV","4","0",NA,"primary breast cancer"
"GSM519239","BRC123","GSM519239","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 1","follow_up_duration (years): 4.6","event_metastasis: 1","time_to_metastasis (years): 3.2","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.3","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC123","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519239/suppl/GSM519239.CEL.gz","54627","yes","38","1","1","4.6","female","0","1",NA,"others","1","type IV","2","3.2","1.3","primary breast cancer"
"GSM519240","BRC124","GSM519240","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 12.3","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC124","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519240/suppl/GSM519240.CEL.gz","54627","no","54","0","0","12.3","female","0","1",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519241","BRC125","GSM519241","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC125","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519241/suppl/GSM519241.CEL.gz","54627","yes","42","0","0","11","female","0","0",NA,"CMF","NA","type IV","2",NA,NA,"primary breast cancer"
"GSM519242","BRC126","GSM519242","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC126","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519242/suppl/GSM519242.CEL.gz","54627","no","45","0","0","11.1","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519243","BRC127","GSM519243","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 10.8","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC127","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519243/suppl/GSM519243.CEL.gz","54627","yes","38","0","0","10.8","female","0","1",NA,"others","0","type II","2",NA,NA,"primary breast cancer"
"GSM519244","BRC128","GSM519244","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC128","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519244/suppl/GSM519244.CEL.gz","54627","yes","53","0","0","11","female","0","2",NA,"CMF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519245","BRC129","GSM519245","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 7","event_metastasis: 1","time_to_metastasis (years): 3.9","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC129","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519245/suppl/GSM519245.CEL.gz","54627","yes","46","1","1","7","female","0","0",NA,"CMF","0","type IV","2","3.9",NA,"primary breast cancer"
"GSM519246","BRC130","GSM519246","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 1","follow_up_duration (years): 8.9","event_metastasis: 1","time_to_metastasis (years): 6.8","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC130","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519246/suppl/GSM519246.CEL.gz","54627","yes","50","1","1","8.9","female","0","1",NA,"CMF","0","type VI","1","6.8",NA,"primary breast cancer"
"GSM519247","BRC131","GSM519247","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 0","follow_up_duration (years): 12.6","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC131","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519247/suppl/GSM519247.CEL.gz","54627","yes","37","0","0","12.6","female","0","0",NA,"CMF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519248","BRC132","GSM519248","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 1","follow_up_duration (years): 5.9","event_metastasis: 1","time_to_metastasis (years): 5.3","subtype: type VI","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC132","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519248/suppl/GSM519248.CEL.gz","54627","yes","39","1","1","5.9","female","0","3",NA,"others","0","type VI","2","5.3",NA,"primary breast cancer"
"GSM519249","BRC133","GSM519249","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 11.2","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC133","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519249/suppl/GSM519249.CEL.gz","54627","yes","58","0","0","11.2","female","0","2",NA,"CMF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519250","BRC134","GSM519250","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 61","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC134","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519250/suppl/GSM519250.CEL.gz","54627","no","61","0","0","11","female","0","1",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519251","BRC135","GSM519251","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 30","event_death: 0","follow_up_duration (years): 11.3","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC135","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519251/suppl/GSM519251.CEL.gz","54627","yes","30","0","0","11.3","female","0","2",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519252","BRC136","GSM519252","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 11.6","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC136","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519252/suppl/GSM519252.CEL.gz","54627","no","62","0","0","11.6","female","0","1",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519253","BRC137","GSM519253","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 1","follow_up_duration (years): 2.4","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type VI","t_stage: 3","n_stage: 2","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC137","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519253/suppl/GSM519253.CEL.gz","54627","yes","62","1","1","2.4","female","1","2","yes","others","0","type VI","3","0",NA,"primary breast cancer"
"GSM519254","BRC138","GSM519254","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 11.9","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC138","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519254/suppl/GSM519254.CEL.gz","54627","no","43","0","0","11.9","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519255","BRC139","GSM519255","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 12.7","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC139","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519255/suppl/GSM519255.CEL.gz","54627","yes","41","0","0","12.7","female","0","3",NA,"others","0","type V","2",NA,NA,"primary breast cancer"
"GSM519256","BRC140","GSM519256","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 12.8","event_metastasis: 1","time_to_metastasis (years): 10.6","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC140","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519256/suppl/GSM519256.CEL.gz","54627","yes","43","0","1","12.8","female","0","0",NA,"CAF","0","type VI","1","10.6",NA,"primary breast cancer"
"GSM519257","BRC141","GSM519257","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 27","event_death: 1","follow_up_duration (years): 4.6","event_metastasis: 1","time_to_metastasis (years): 1.7","subtype: type IV","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC141","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519257/suppl/GSM519257.CEL.gz","54627","yes","27","1","1","4.6","female","0","1",NA,"others","0","type IV","1","1.7",NA,"primary breast cancer"
"GSM519258","BRC142","GSM519258","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 10.9","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC142","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519258/suppl/GSM519258.CEL.gz","54627","no","58","0","0","10.9","female","0","1",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519259","BRC143","GSM519259","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 1","follow_up_duration (years): 11.4","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type III","t_stage: 4","n_stage: 2","m_stage: 1","regional_relapse: 1","time_to_relapse (years): 6.5","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC143","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519259/suppl/GSM519259.CEL.gz","54627","yes","43","1","1","11.4","female","1","2","yes","others","1","type III","4","0","6.5","primary breast cancer"
"GSM519260","BRC144","GSM519260","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 0","follow_up_duration (years): 12.5","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 5.0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC144","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519260/suppl/GSM519260.CEL.gz","54627","yes","42","0","0","12.5","female","0","3",NA,"others","1","type VI","2",NA,"5.0","primary breast cancer"
"GSM519261","BRC145","GSM519261","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 12.5","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC145","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519261/suppl/GSM519261.CEL.gz","54627","yes","41","0","0","12.5","female","0","0",NA,"CMF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519262","BRC146","GSM519262","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 60","event_death: 0","follow_up_duration (years): 9.9","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC146","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519262/suppl/GSM519262.CEL.gz","54627","no","60","0","0","9.9","female","0","0",NA,"no","0","type II","2",NA,NA,"primary breast cancer"
"GSM519263","BRC147","GSM519263","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 2.9","event_metastasis: 1","time_to_metastasis (years): 2","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC147","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519263/suppl/GSM519263.CEL.gz","54627","yes","46","1","1","2.9","female","0","1",NA,"CMF","0","type III","2","2",NA,"primary breast cancer"
"GSM519264","BRC148","GSM519264","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC148","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519264/suppl/GSM519264.CEL.gz","54627","no","57","0","0","11.1","female","0","0",NA,"no","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519265","BRC149","GSM519265","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 1","follow_up_duration (years): 5.7","event_metastasis: 1","time_to_metastasis (years): 5.1","subtype: type II","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC149","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519265/suppl/GSM519265.CEL.gz","54627","yes","51","1","1","5.7","female","0","2","yes","others","0","type II","3","5.1",NA,"primary breast cancer"
"GSM519266","BRC150","GSM519266","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 1","follow_up_duration (years): 1","event_metastasis: 1","time_to_metastasis (years): 0.9","subtype: type II","t_stage: 4","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC150","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519266/suppl/GSM519266.CEL.gz","54627","yes","58","1","1","1","female","0","3",NA,"others","0","type II","4","0.9",NA,"primary breast cancer"
"GSM519267","BRC151","GSM519267","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 13.1","event_metastasis: 1","time_to_metastasis (years): 8.8","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 8.7","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC151","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519267/suppl/GSM519267.CEL.gz","54627","yes","48","0","1","13.1","female","0","1",NA,"CMF","1","type II","2","8.8","8.7","primary breast cancer"
"GSM519268","BRC152","GSM519268","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 36","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC152","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519268/suppl/GSM519268.CEL.gz","54627","yes","36","0","0","11.1","female","0","0",NA,"CMF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519269","BRC153","GSM519269","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 1","follow_up_duration (years): 5.5","event_metastasis: 1","time_to_metastasis (years): 2.9","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 2.6","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC153","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519269/suppl/GSM519269.CEL.gz","54627","yes","42","1","1","5.5","female","0","2",NA,"others","1","type III","2","2.9","2.6","primary breast cancer"
"GSM519270","BRC154","GSM519270","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 12.1","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC154","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519270/suppl/GSM519270.CEL.gz","54627","yes","46","0","0","12.1","female","0","2",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519271","BRC155","GSM519271","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC155","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519271/suppl/GSM519271.CEL.gz","54627","no","51","0","0","9.4","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519272","BRC156","GSM519272","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 71","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC156","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519272/suppl/GSM519272.CEL.gz","54627","no","71","0","0","11.1","female","0","0",NA,"no","0","type II","2",NA,NA,"primary breast cancer"
"GSM519273","BRC157","GSM519273","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 12.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC157","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519273/suppl/GSM519273.CEL.gz","54627","no","51","0","0","12.1","female","0","1",NA,"no","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519274","BRC158","GSM519274","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 31","event_death: 0","follow_up_duration (years): 10.8","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC158","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519274/suppl/GSM519274.CEL.gz","54627","yes","31","0","0","10.8","female","0","2",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519275","BRC159","GSM519275","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 0","subtype: type V","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC159","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519275/suppl/GSM519275.CEL.gz","54627","yes","34","0","0","10.2","female","0","2","yes","others","0","type V","3",NA,NA,"primary breast cancer"
"GSM519276","BRC160","GSM519276","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 0","follow_up_duration (years): 12.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC160","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519276/suppl/GSM519276.CEL.gz","54627","yes","51","0","0","12.4","female","0","1",NA,"CMF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519277","BRC161","GSM519277","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 33","event_death: 0","follow_up_duration (years): 7.4","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC161","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519277/suppl/GSM519277.CEL.gz","54627","yes","33","0","0","7.4","female","0","1",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519278","BRC162","GSM519278","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 11.6","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC162","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519278/suppl/GSM519278.CEL.gz","54627","no","43","0","0","11.6","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519279","BRC163","GSM519279","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 1","follow_up_duration (years): 7.5","event_metastasis: 1","time_to_metastasis (years): 4.8","subtype: type III","t_stage: 4","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC163","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519279/suppl/GSM519279.CEL.gz","54627","yes","48","1","1","7.5","female","0","2",NA,"others","0","type III","4","4.8",NA,"primary breast cancer"
"GSM519280","BRC164","GSM519280","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 56","event_death: 1","follow_up_duration (years): 2.2","event_metastasis: 1","time_to_metastasis (years): 1.3","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC164","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519280/suppl/GSM519280.CEL.gz","54627","yes","56","1","1","2.2","female","0","3",NA,"others","0","type VI","3","1.3",NA,"primary breast cancer"
"GSM519281","BRC165","GSM519281","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 7.1","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC165","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519281/suppl/GSM519281.CEL.gz","54627","yes","41","0","0","7.1","female","0","0",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519282","BRC166","GSM519282","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC166","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519282/suppl/GSM519282.CEL.gz","54627","yes","58","0","0","10.2","female","0","1",NA,"CAF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519283","BRC167","GSM519283","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 10.3","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC167","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519283/suppl/GSM519283.CEL.gz","54627","yes","53","0","0","10.3","female","0","0",NA,"CMF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519284","BRC168","GSM519284","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 11.8","event_metastasis: 0","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC168","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519284/suppl/GSM519284.CEL.gz","54627","yes","44","0","0","11.8","female","0","3","yes","others","0","type VI","3",NA,NA,"primary breast cancer"
"GSM519285","BRC169","GSM519285","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 1","follow_up_duration (years): 11.5","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC169","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519285/suppl/GSM519285.CEL.gz","54627","no","57","1","0","11.5","female","0","0",NA,"no","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519286","BRC170","GSM519286","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 10.5","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 9.5","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC170","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519286/suppl/GSM519286.CEL.gz","54627","yes","45","0","0","10.5","female","0","2",NA,"others","1","type VI","1",NA,"9.5","primary breast cancer"
"GSM519287","BRC171","GSM519287","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 11.7","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 8.1","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC171","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519287/suppl/GSM519287.CEL.gz","54627","yes","41","0","0","11.7","female","0","1",NA,"CMF","1","type VI","2",NA,"8.1","primary breast cancer"
"GSM519288","BRC172","GSM519288","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 11.7","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC172","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519288/suppl/GSM519288.CEL.gz","54627","yes","54","0","0","11.7","female","0","2",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519289","BRC173","GSM519289","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 64","event_death: 1","follow_up_duration (years): 1.6","event_metastasis: 0","subtype: type II","t_stage: 3","n_stage: 1","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC173","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519289/suppl/GSM519289.CEL.gz","54627","no","64","1","0","1.6","female","0","1",NA,"no","NA","type II","3",NA,NA,"primary breast cancer"
"GSM519290","BRC174","GSM519290","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 56","event_death: 0","follow_up_duration (years): 10","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC174","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519290/suppl/GSM519290.CEL.gz","54627","yes","56","0","0","10","female","0","1",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519291","BRC175","GSM519291","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 11.7","event_metastasis: 1","time_to_metastasis (years): 7.3","subtype: type VI","t_stage: 1","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC175","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519291/suppl/GSM519291.CEL.gz","54627","yes","58","0","1","11.7","female","0","3",NA,"others","0","type VI","1","7.3",NA,"primary breast cancer"
"GSM519292","BRC176","GSM519292","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 12.5","event_metastasis: 1","time_to_metastasis (years): 2.4","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC176","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519292/suppl/GSM519292.CEL.gz","54627","yes","38","0","1","12.5","female","0","0",NA,"CMF","0","type IV","1","2.4",NA,"primary breast cancer"
"GSM519293","BRC177","GSM519293","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 1","follow_up_duration (years): 1.3","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type II","t_stage: 3","n_stage: 3","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC177","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519293/suppl/GSM519293.CEL.gz","54627","yes","42","1","1","1.3","female","1","3",NA,"others","0","type II","3","0",NA,"primary breast cancer"
"GSM519294","BRC178","GSM519294","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 69","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC178","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519294/suppl/GSM519294.CEL.gz","54627","no","69","0","0","10.2","female","0","0",NA,"no","0","type II","2",NA,NA,"primary breast cancer"
"GSM519295","BRC179","GSM519295","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 79","event_death: 0","follow_up_duration (years): 10.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC179","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519295/suppl/GSM519295.CEL.gz","54627","no","79","0","0","10.4","female","0","1",NA,"no","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519296","BRC180","GSM519296","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 0","follow_up_duration (years): 11.2","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC180","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519296/suppl/GSM519296.CEL.gz","54627","yes","37","0","0","11.2","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519297","BRC181","GSM519297","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 9.8","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC181","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519297/suppl/GSM519297.CEL.gz","54627","yes","44","0","0","9.8","female","0","3",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519298","BRC182","GSM519298","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 1","follow_up_duration (years): 1.2","event_metastasis: 1","time_to_metastasis (years): 1.2","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC182","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519298/suppl/GSM519298.CEL.gz","54627","yes","48","1","1","1.2","female","0","2",NA,"others","0","type II","2","1.2",NA,"primary breast cancer"
"GSM519299","BRC183","GSM519299","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC183","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519299/suppl/GSM519299.CEL.gz","54627","yes","43","0","0","9.4","female","0","0","yes","others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519300","BRC184","GSM519300","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 0","follow_up_duration (years): 11.3","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC184","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519300/suppl/GSM519300.CEL.gz","54627","yes","50","0","0","11.3","female","0","2",NA,"others","0","type II","2",NA,NA,"primary breast cancer"
"GSM519301","BRC185","GSM519301","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 30","event_death: 0","follow_up_duration (years): 10","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC185","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519301/suppl/GSM519301.CEL.gz","54627","yes","30","0","0","10","female","0","0",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519302","BRC186","GSM519302","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 36","event_death: 0","follow_up_duration (years): 11.5","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC186","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519302/suppl/GSM519302.CEL.gz","54627","yes","36","0","0","11.5","female","0","1",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519303","BRC187","GSM519303","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 1","follow_up_duration (years): 7.1","event_metastasis: 1","time_to_metastasis (years): 6.1","subtype: type II","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC187","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519303/suppl/GSM519303.CEL.gz","54627","yes","57","1","1","7.1","female","0","0",NA,"CMF","0","type II","1","6.1",NA,"primary breast cancer"
"GSM519304","BRC188","GSM519304","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 1","follow_up_duration (years): 2.1","event_metastasis: 1","time_to_metastasis (years): 1.5","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC188","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519304/suppl/GSM519304.CEL.gz","54627","yes","49","1","1","2.1","female","0","1",NA,"CAF","0","type I","2","1.5",NA,"primary breast cancer"
"GSM519305","BRC189","GSM519305","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 1","follow_up_duration (years): 1.8","event_metastasis: 1","time_to_metastasis (years): 1.1","subtype: type II","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC189","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519305/suppl/GSM519305.CEL.gz","54627","yes","41","1","1","1.8","female","0","3","yes","others","0","type II","2","1.1",NA,"primary breast cancer"
"GSM519306","BRC190","GSM519306","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 1","follow_up_duration (years): 5.8","event_metastasis: 1","time_to_metastasis (years): 2.4","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC190","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519306/suppl/GSM519306.CEL.gz","54627","yes","52","1","1","5.8","female","0","1",NA,"CAF","0","type V","1","2.4",NA,"primary breast cancer"
"GSM519307","BRC191","GSM519307","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 11.3","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC191","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519307/suppl/GSM519307.CEL.gz","54627","yes","47","0","0","11.3","female","0","0",NA,"CMF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519308","BRC192","GSM519308","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC192","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519308/suppl/GSM519308.CEL.gz","54627","no","63","0","0","11.1","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519309","BRC193","GSM519309","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 31","event_death: 1","follow_up_duration (years): 1.6","event_metastasis: 1","time_to_metastasis (years): 1.1","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC193","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519309/suppl/GSM519309.CEL.gz","54627","yes","31","1","1","1.6","female","0","2","yes","others","0","type VI","2","1.1",NA,"primary breast cancer"
"GSM519310","BRC194","GSM519310","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 1","follow_up_duration (years): 3.1","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 3","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC194","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519310/suppl/GSM519310.CEL.gz","54627","yes","34","1","0","3.1","female","0","3",NA,"others","NA","type IV","1",NA,NA,"primary breast cancer"
"GSM519311","BRC195","GSM519311","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 30","event_death: 0","follow_up_duration (years): 9.5","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC195","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519311/suppl/GSM519311.CEL.gz","54627","yes","30","0","0","9.5","female","0","0","yes","others","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519312","BRC196","GSM519312","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC196","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519312/suppl/GSM519312.CEL.gz","54627","yes","39","0","0","11.1","female","0","0",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519313","BRC197","GSM519313","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 11.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC197","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519313/suppl/GSM519313.CEL.gz","54627","yes","38","0","0","11.4","female","0","2",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519314","BRC198","GSM519314","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC198","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519314/suppl/GSM519314.CEL.gz","54627","yes","43","0","0","9.4","female","0","0",NA,"CMF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519315","BRC199","GSM519315","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 10.4","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC199","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519315/suppl/GSM519315.CEL.gz","54627","yes","43","0","0","10.4","female","0","1",NA,"CAF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519316","BRC200","GSM519316","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC200","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519316/suppl/GSM519316.CEL.gz","54627","yes","49","0","0","11","female","0","0",NA,"CMF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519317","BRC201","GSM519317","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 67","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC201","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519317/suppl/GSM519317.CEL.gz","54627","yes","67","0","0","11.1","female","0","2",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519318","BRC202","GSM519318","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 75","event_death: 0","follow_up_duration (years): 6","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC202","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519318/suppl/GSM519318.CEL.gz","54627","no","75","0","0","6","female","0","3",NA,"no","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519319","BRC203","GSM519319","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 9.7","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC203","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519319/suppl/GSM519319.CEL.gz","54627","yes","41","0","0","9.7","female","0","1",NA,"CAF","NA","type V","2",NA,NA,"primary breast cancer"
"GSM519320","BRC204","GSM519320","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 70","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type VI","t_stage: 4","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC204","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519320/suppl/GSM519320.CEL.gz","54627","no","70","0","0","11","female","0","0",NA,"no","0","type VI","4",NA,NA,"primary breast cancer"
"GSM519321","BRC205","GSM519321","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 11.2","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC205","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519321/suppl/GSM519321.CEL.gz","54627","yes","46","0","0","11.2","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519322","BRC206","GSM519322","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 3.4","event_metastasis: 1","time_to_metastasis (years): 1","subtype: type III","t_stage: 3","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC206","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519322/suppl/GSM519322.CEL.gz","54627","yes","46","1","1","3.4","female","0","1",NA,"CAF","0","type III","3","1",NA,"primary breast cancer"
"GSM519323","BRC207","GSM519323","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 1","follow_up_duration (years): 10.3","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 4.6","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC207","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519323/suppl/GSM519323.CEL.gz","54627","yes","37","1","0","10.3","female","0","2",NA,"CMF","1","type V","2",NA,"4.6","primary breast cancer"
"GSM519324","BRC208","GSM519324","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 1","follow_up_duration (years): 4.7","event_metastasis: 1","time_to_metastasis (years): 1.6","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: unknown","regimen (caf vs cmf): unknown","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC208","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519324/suppl/GSM519324.CEL.gz","54627","unknown","38","1","1","4.7","female","0","0","yes","unknown","0","type I","2","1.6",NA,"primary breast cancer"
"GSM519325","BRC209","GSM519325","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC209","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519325/suppl/GSM519325.CEL.gz","54627","yes","55","0","0","11","female","0","2",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519326","BRC210","GSM519326","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 32","event_death: 0","follow_up_duration (years): 11.2","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC210","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519326/suppl/GSM519326.CEL.gz","54627","yes","32","0","0","11.2","female","0","1",NA,"CAF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519327","BRC211","GSM519327","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 6.2","event_metastasis: 1","time_to_metastasis (years): 3.1","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC211","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519327/suppl/GSM519327.CEL.gz","54627","yes","46","1","1","6.2","female","0","0",NA,"CMF","NA","type IV","2","3.1",NA,"primary breast cancer"
"GSM519328","BRC212","GSM519328","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 72","event_death: 0","follow_up_duration (years): 7","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC212","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519328/suppl/GSM519328.CEL.gz","54627","no","72","0","0","7","female","0","2",NA,"no","0","type V","2",NA,NA,"primary breast cancer"
"GSM519329","BRC213","GSM519329","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 33","event_death: 0","follow_up_duration (years): 9.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC213","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519329/suppl/GSM519329.CEL.gz","54627","yes","33","0","0","9.1","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519330","BRC214","GSM519330","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 1","time_to_metastasis (years): 5.7","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC214","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519330/suppl/GSM519330.CEL.gz","54627","yes","40","0","1","10.2","female","0","1",NA,"CMF","0","type VI","2","5.7",NA,"primary breast cancer"
"GSM519331","BRC215","GSM519331","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 11.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC215","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519331/suppl/GSM519331.CEL.gz","54627","yes","45","0","0","11.1","female","0","1",NA,"CAF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519332","BRC216","GSM519332","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC216","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519332/suppl/GSM519332.CEL.gz","54627","yes","39","0","0","11","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519333","BRC217","GSM519333","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 1","follow_up_duration (years): 7.5","event_metastasis: 1","time_to_metastasis (years): 3.2","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC217","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519333/suppl/GSM519333.CEL.gz","54627","yes","47","1","1","7.5","female","0","0",NA,"CMF","0","type IV","2","3.2",NA,"primary breast cancer"
"GSM519334","BRC218","GSM519334","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 9.5","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC218","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519334/suppl/GSM519334.CEL.gz","54627","yes","54","0","0","9.5","female","0","1",NA,"CAF","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519335","BRC219","GSM519335","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC219","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519335/suppl/GSM519335.CEL.gz","54627","no","58","0","0","11","female","0","1",NA,"no","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519336","BRC220","GSM519336","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 31","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 7.5","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC220","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519336/suppl/GSM519336.CEL.gz","54627","yes","31","0","0","11","female","0","1",NA,"CAF","1","type VI","2",NA,"7.5","primary breast cancer"
"GSM519337","BRC221","GSM519337","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 81","event_death: 1","follow_up_duration (years): 2.7","event_metastasis: 1","time_to_metastasis (years): 2.6","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC221","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519337/suppl/GSM519337.CEL.gz","54627","no","81","1","1","2.7","female","0","2",NA,"no","0","type IV","2","2.6",NA,"primary breast cancer"
"GSM519338","BRC222","GSM519338","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 10","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC222","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519338/suppl/GSM519338.CEL.gz","54627","yes","43","0","0","10","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519339","BRC223","GSM519339","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 66","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC223","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519339/suppl/GSM519339.CEL.gz","54627","no","66","0","0","11","female","0","0",NA,"no","NA","type V","2",NA,NA,"primary breast cancer"
"GSM519340","BRC224","GSM519340","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 11","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC224","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519340/suppl/GSM519340.CEL.gz","54627","no","48","0","0","11","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519341","BRC225","GSM519341","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 10.8","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC225","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519341/suppl/GSM519341.CEL.gz","54627","yes","62","0","0","10.8","female","0","0",NA,"CMF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519342","BRC226","GSM519342","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 36","event_death: 1","follow_up_duration (years): 5.5","event_metastasis: 1","time_to_metastasis (years): 2.4","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC226","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519342/suppl/GSM519342.CEL.gz","54627","yes","36","1","1","5.5","female","0","0",NA,"CMF","NA","type IV","1","2.4",NA,"primary breast cancer"
"GSM519343","BRC227","GSM519343","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 10","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC227","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519343/suppl/GSM519343.CEL.gz","54627","no","55","0","0","10","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519344","BRC228","GSM519344","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 9.9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC228","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519344/suppl/GSM519344.CEL.gz","54627","yes","43","0","0","9.9","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519345","BRC229","GSM519345","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 9.2","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC229","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519345/suppl/GSM519345.CEL.gz","54627","no","40","0","0","9.2","female","0","0",NA,"no","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519346","BRC230","GSM519346","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 10.6","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC230","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519346/suppl/GSM519346.CEL.gz","54627","yes","54","0","0","10.6","female","0","3",NA,"others","0","type I","2",NA,NA,"primary breast cancer"
"GSM519347","BRC231","GSM519347","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 60","event_death: 1","follow_up_duration (years): 10.1","event_metastasis: 1","time_to_metastasis (years): 0.2","subtype: type IV","t_stage: 1","n_stage: 3","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 0.2","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC231","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519347/suppl/GSM519347.CEL.gz","54627","yes","60","1","1","10.1","female","0","3",NA,"others","1","type IV","1","0.2","0.2","primary breast cancer"
"GSM519348","BRC232","GSM519348","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 10.5","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC232","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519348/suppl/GSM519348.CEL.gz","54627","yes","47","0","0","10.5","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519349","BRC233","GSM519349","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 35","event_death: 1","follow_up_duration (years): 1.9","event_metastasis: 1","time_to_metastasis (years): 1.8","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC233","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519349/suppl/GSM519349.CEL.gz","54627","yes","35","1","1","1.9","female","0","2","yes","others","0","type VI","2","1.8",NA,"primary breast cancer"
"GSM519350","BRC234","GSM519350","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 9.2","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC234","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519350/suppl/GSM519350.CEL.gz","54627","yes","52","0","0","9.2","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519351","BRC235","GSM519351","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 7.9","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC235","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519351/suppl/GSM519351.CEL.gz","54627","no","44","0","0","7.9","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519352","BRC236","GSM519352","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 8.1","event_metastasis: 1","time_to_metastasis (years): 4.7","subtype: type III","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.7","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC236","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519352/suppl/GSM519352.CEL.gz","54627","yes","46","1","1","8.1","female","0","3","yes","others","1","type III","2","4.7","1.7","primary breast cancer"
"GSM519353","BRC237","GSM519353","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 82","event_death: 0","follow_up_duration (years): 7.5","event_metastasis: 0","subtype: type V","t_stage: 4","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC237","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519353/suppl/GSM519353.CEL.gz","54627","no","82","0","0","7.5","female","0","1",NA,"no","0","type V","4",NA,NA,"primary breast cancer"
"GSM519354","BRC238","GSM519354","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC238","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519354/suppl/GSM519354.CEL.gz","54627","yes","38","0","0","9.4","female","0","2",NA,"CAF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519355","BRC239","GSM519355","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 10.6","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC239","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519355/suppl/GSM519355.CEL.gz","54627","yes","38","0","0","10.6","female","0","3",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519356","BRC240","GSM519356","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC240","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519356/suppl/GSM519356.CEL.gz","54627","yes","45","0","0","10.2","female","0","0",NA,"CAF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519357","BRC241","GSM519357","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 1","follow_up_duration (years): 5.3","event_metastasis: 1","time_to_metastasis (years): 3.9","subtype: type IV","t_stage: 4","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC241","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519357/suppl/GSM519357.CEL.gz","54627","yes","41","1","1","5.3","female","0","2","yes","others","0","type IV","4","3.9",NA,"primary breast cancer"
"GSM519358","BRC242","GSM519358","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 8.9","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC242","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519358/suppl/GSM519358.CEL.gz","54627","yes","47","0","0","8.9","female","0","1",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519359","BRC243","GSM519359","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 84","event_death: 1","follow_up_duration (years): 1.3","event_metastasis: 1","time_to_metastasis (years): 1.3","subtype: type III","t_stage: 4","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: unknown","regimen (caf vs cmf): unknown","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC243","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519359/suppl/GSM519359.CEL.gz","54627","unknown","84","1","1","1.3","female","0","1",NA,"unknown","0","type III","4","1.3",NA,"primary breast cancer"
"GSM519360","BRC244","GSM519360","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 54","event_death: 0","follow_up_duration (years): 9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC244","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519360/suppl/GSM519360.CEL.gz","54627","yes","54","0","0","9","female","0","3",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519361","BRC245","GSM519361","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 66","event_death: 0","follow_up_duration (years): 8.4","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC245","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519361/suppl/GSM519361.CEL.gz","54627","no","66","0","0","8.4","female","0","0",NA,"no","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519362","BRC246","GSM519362","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 0","follow_up_duration (years): 9.1","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC246","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519362/suppl/GSM519362.CEL.gz","54627","yes","63","0","0","9.1","female","0","0",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519363","BRC247","GSM519363","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 8.7","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC247","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519363/suppl/GSM519363.CEL.gz","54627","yes","55","0","0","8.7","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519364","BRC248","GSM519364","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 10.3","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC248","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519364/suppl/GSM519364.CEL.gz","54627","yes","47","0","0","10.3","female","0","3","yes","others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519365","BRC249","GSM519365","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 45","event_death: 0","follow_up_duration (years): 9.6","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC249","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519365/suppl/GSM519365.CEL.gz","54627","yes","45","0","0","9.6","female","0","2",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519366","BRC250","GSM519366","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 56","event_death: 0","follow_up_duration (years): 10.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC250","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519366/suppl/GSM519366.CEL.gz","54627","yes","56","0","0","10.1","female","0","0",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519367","BRC251","GSM519367","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 1","follow_up_duration (years): 3.7","event_metastasis: 1","time_to_metastasis (years): 2.7","subtype: type I","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC251","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519367/suppl/GSM519367.CEL.gz","54627","yes","38","1","1","3.7","female","0","1",NA,"CMF","NA","type I","2","2.7",NA,"primary breast cancer"
"GSM519368","BRC252","GSM519368","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 1","follow_up_duration (years): 3.4","event_metastasis: 1","time_to_metastasis (years): 1.7","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC252","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519368/suppl/GSM519368.CEL.gz","54627","yes","49","1","1","3.4","female","0","0",NA,"others","NA","type VI","1","1.7",NA,"primary breast cancer"
"GSM519369","BRC253","GSM519369","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 10.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC253","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519369/suppl/GSM519369.CEL.gz","54627","yes","53","0","0","10.4","female","0","2",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519370","BRC254","GSM519370","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 1","follow_up_duration (years): 5","event_metastasis: 1","time_to_metastasis (years): 3.4","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.3","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC254","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519370/suppl/GSM519370.CEL.gz","54627","yes","34","1","1","5","female","0","0",NA,"CMF","1","type VI","1","3.4","1.3","primary breast cancer"
"GSM519371","BRC255","GSM519371","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 1","follow_up_duration (years): 7.5","event_metastasis: 1","time_to_metastasis (years): 4.2","subtype: type IV","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC255","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519371/suppl/GSM519371.CEL.gz","54627","yes","38","1","1","7.5","female","0","2",NA,"others","0","type IV","1","4.2",NA,"primary breast cancer"
"GSM519372","BRC256","GSM519372","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 10.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC256","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519372/suppl/GSM519372.CEL.gz","54627","yes","41","0","0","10.1","female","0","3",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519373","BRC257","GSM519373","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 7.2","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC257","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519373/suppl/GSM519373.CEL.gz","54627","yes","52","0","0","7.2","female","0","3",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519374","BRC258","GSM519374","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 10.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC258","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519374/suppl/GSM519374.CEL.gz","54627","yes","40","0","0","10.1","female","0","0",NA,"CAF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519375","BRC259","GSM519375","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 8.9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC259","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519375/suppl/GSM519375.CEL.gz","54627","yes","43","0","0","8.9","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519376","BRC260","GSM519376","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC260","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519376/suppl/GSM519376.CEL.gz","54627","yes","62","0","0","9.4","female","0","0",NA,"CAF","NA","type IV","2",NA,NA,"primary breast cancer"
"GSM519377","BRC261","GSM519377","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 0","follow_up_duration (years): 10.2","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC261","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519377/suppl/GSM519377.CEL.gz","54627","yes","62","0","0","10.2","female","0","2",NA,"others","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519378","BRC262","GSM519378","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC262","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519378/suppl/GSM519378.CEL.gz","54627","yes","44","0","0","9.4","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519379","BRC263","GSM519379","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 9.2","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC263","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519379/suppl/GSM519379.CEL.gz","54627","yes","41","0","0","9.2","female","0","0",NA,"CMF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519380","BRC264","GSM519380","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 9.2","event_metastasis: 0","subtype: type I","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC264","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519380/suppl/GSM519380.CEL.gz","54627","yes","38","0","0","9.2","female","0","0",NA,"CAF","0","type I","2",NA,NA,"primary breast cancer"
"GSM519381","BRC265","GSM519381","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 0","follow_up_duration (years): 9.9","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC265","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519381/suppl/GSM519381.CEL.gz","54627","yes","43","0","0","9.9","female","0","1",NA,"CAF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519382","BRC266","GSM519382","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 1","follow_up_duration (years): 3.1","event_metastasis: 1","time_to_metastasis (years): 2.9","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC266","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519382/suppl/GSM519382.CEL.gz","54627","yes","48","1","1","3.1","female","0","2",NA,"others","0","type VI","2","2.9",NA,"primary breast cancer"
"GSM519383","BRC267","GSM519383","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 9.8","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC267","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519383/suppl/GSM519383.CEL.gz","54627","no","39","0","0","9.8","female","0","0",NA,"no","0","type V","1",NA,NA,"primary breast cancer"
"GSM519384","BRC268","GSM519384","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 8.3","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC268","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519384/suppl/GSM519384.CEL.gz","54627","yes","44","0","0","8.3","female","0","0",NA,"CMF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519385","BRC269","GSM519385","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 0","follow_up_duration (years): 9.8","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC269","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519385/suppl/GSM519385.CEL.gz","54627","yes","37","0","0","9.8","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519386","BRC270","GSM519386","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 10.4","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type IV","t_stage: 4","n_stage: 3","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC270","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519386/suppl/GSM519386.CEL.gz","54627","yes","41","0","1","10.4","female","1","3",NA,"CMF","0","type IV","4","0",NA,"primary breast cancer"
"GSM519387","BRC271","GSM519387","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 8.9","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC271","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519387/suppl/GSM519387.CEL.gz","54627","yes","53","0","0","8.9","female","0","1",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519388","BRC272","GSM519388","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 36","event_death: 0","follow_up_duration (years): 9.5","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC272","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519388/suppl/GSM519388.CEL.gz","54627","yes","36","0","0","9.5","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519389","BRC273","GSM519389","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type I","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 9.5","event_metastasis: 0","subtype: type I","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC273","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519389/suppl/GSM519389.CEL.gz","54627","yes","55","0","0","9.5","female","0","0",NA,"CMF","0","type I","1",NA,NA,"primary breast cancer"
"GSM519390","BRC274","GSM519390","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 9.6","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC274","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519390/suppl/GSM519390.CEL.gz","54627","yes","52","0","0","9.6","female","0","2",NA,"others","0","type V","1",NA,NA,"primary breast cancer"
"GSM519391","BRC275","GSM519391","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 63","event_death: 0","follow_up_duration (years): 9.6","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 6.0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC275","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519391/suppl/GSM519391.CEL.gz","54627","yes","63","0","0","9.6","female","0","1",NA,"CAF","1","type VI","1",NA,"6.0","primary breast cancer"
"GSM519392","BRC276","GSM519392","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 8.3","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC276","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519392/suppl/GSM519392.CEL.gz","54627","yes","47","0","0","8.3","female","0","2","yes","others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519393","BRC277","GSM519393","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC277","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519393/suppl/GSM519393.CEL.gz","54627","yes","49","0","0","9.4","female","0","0",NA,"CAF","NA","type III","2",NA,NA,"primary breast cancer"
"GSM519394","BRC278","GSM519394","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 9.4","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC278","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519394/suppl/GSM519394.CEL.gz","54627","yes","48","0","0","9.4","female","0","0",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519395","BRC279","GSM519395","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 8.6","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC279","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519395/suppl/GSM519395.CEL.gz","54627","no","47","0","0","8.6","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519396","BRC280","GSM519396","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 1","follow_up_duration (years): 6.6","event_metastasis: 1","time_to_metastasis (years): 5.1","subtype: type IV","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 3.7","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC280","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519396/suppl/GSM519396.CEL.gz","54627","yes","41","1","1","6.6","female","0","1",NA,"CAF","1","type IV","1","5.1","3.7","primary breast cancer"
"GSM519397","BRC281","GSM519397","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 9.3","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC281","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519397/suppl/GSM519397.CEL.gz","54627","yes","53","0","0","9.3","female","0","1",NA,"CAF","NA","type V","1",NA,NA,"primary breast cancer"
"GSM519398","BRC282","GSM519398","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 7","event_metastasis: 1","time_to_metastasis (years): 5.7","subtype: type IV","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC282","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519398/suppl/GSM519398.CEL.gz","54627","yes","46","1","1","7","female","0","2",NA,"others","0","type IV","2","5.7",NA,"primary breast cancer"
"GSM519399","BRC283","GSM519399","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 9.1","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC283","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519399/suppl/GSM519399.CEL.gz","54627","yes","57","0","0","9.1","female","0","0",NA,"CAF","0","type III","1",NA,NA,"primary breast cancer"
"GSM519400","BRC284","GSM519400","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 43","event_death: 1","follow_up_duration (years): 3.3","event_metastasis: 1","time_to_metastasis (years): 0.9","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC284","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519400/suppl/GSM519400.CEL.gz","54627","yes","43","1","1","3.3","female","0","2","yes","others","0","type VI","2","0.9",NA,"primary breast cancer"
"GSM519401","BRC285","GSM519401","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 47","event_death: 0","follow_up_duration (years): 9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC285","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519401/suppl/GSM519401.CEL.gz","54627","yes","47","0","0","9","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519402","BRC286","GSM519402","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC286","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519402/suppl/GSM519402.CEL.gz","54627","no","48","0","0","8.1","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519403","BRC287","GSM519403","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 1","follow_up_duration (years): 0.4","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: unknown","regimen (caf vs cmf): unknown","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC287","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519403/suppl/GSM519403.CEL.gz","54627","unknown","39","1","0","0.4","female","0","0",NA,"unknown","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519404","BRC288","GSM519404","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 58","event_death: 0","follow_up_duration (years): 9.1","event_metastasis: 0","subtype: type III","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC288","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519404/suppl/GSM519404.CEL.gz","54627","yes","58","0","0","9.1","female","0","2",NA,"others","0","type III","3",NA,NA,"primary breast cancer"
"GSM519405","BRC289","GSM519405","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 42","event_death: 0","follow_up_duration (years): 8.9","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC289","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519405/suppl/GSM519405.CEL.gz","54627","yes","42","0","0","8.9","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519406","BRC290","GSM519406","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 8.9","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC290","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519406/suppl/GSM519406.CEL.gz","54627","no","57","0","0","8.9","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519407","BRC291","GSM519407","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 8.2","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC291","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519407/suppl/GSM519407.CEL.gz","54627","no","40","0","0","8.2","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519408","BRC292","GSM519408","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 7.7","event_metastasis: 0","subtype: type V","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC292","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519408/suppl/GSM519408.CEL.gz","54627","yes","48","0","0","7.7","female","0","0",NA,"CAF","0","type V","2",NA,NA,"primary breast cancer"
"GSM519409","BRC293","GSM519409","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 8.7","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC293","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519409/suppl/GSM519409.CEL.gz","54627","yes","46","0","0","8.7","female","0","2","yes","CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519410","BRC294","GSM519410","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC294","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519410/suppl/GSM519410.CEL.gz","54627","yes","49","0","0","8.1","female","0","0",NA,"others","NA","type IV","2",NA,NA,"primary breast cancer"
"GSM519411","BRC295","GSM519411","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 8.6","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC295","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519411/suppl/GSM519411.CEL.gz","54627","yes","53","0","0","8.6","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519412","BRC296","GSM519412","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 0","follow_up_duration (years): 9","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC296","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519412/suppl/GSM519412.CEL.gz","54627","no","39","0","0","9","female","0","0",NA,"no","0","type III","1",NA,NA,"primary breast cancer"
"GSM519413","BRC297","GSM519413","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 0","follow_up_duration (years): 7.8","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC297","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519413/suppl/GSM519413.CEL.gz","54627","yes","50","0","0","7.8","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519414","BRC298","GSM519414","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 0","follow_up_duration (years): 8.7","event_metastasis: 0","subtype: type III","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC298","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519414/suppl/GSM519414.CEL.gz","54627","yes","34","0","0","8.7","female","0","2","yes","others","0","type III","3",NA,NA,"primary breast cancer"
"GSM519415","BRC299","GSM519415","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 8.4","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC299","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519415/suppl/GSM519415.CEL.gz","54627","yes","53","0","0","8.4","female","0","0",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519416","BRC300","GSM519416","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 59","event_death: 0","follow_up_duration (years): 8.3","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC300","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519416/suppl/GSM519416.CEL.gz","54627","yes","59","0","0","8.3","female","0","3",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519417","BRC301","GSM519417","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 62","event_death: 1","follow_up_duration (years): 2.4","event_metastasis: 1","time_to_metastasis (years): 1.5","subtype: type II","t_stage: 3","n_stage: 1","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 1.5","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC301","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519417/suppl/GSM519417.CEL.gz","54627","yes","62","1","1","2.4","female","0","1","yes","others","1","type II","3","1.5","1.5","primary breast cancer"
"GSM519418","BRC302","GSM519418","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 8.5","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC302","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519418/suppl/GSM519418.CEL.gz","54627","yes","41","0","0","8.5","female","0","0",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519419","BRC303","GSM519419","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 28","event_death: 1","follow_up_duration (years): 2.9","event_metastasis: 1","time_to_metastasis (years): 2.1","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","neoadjuvant chemotherapy: yes","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC303","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519419/suppl/GSM519419.CEL.gz","54627","yes","28","1","1","2.9","female","0","3","yes","others","0","type VI","3","2.1",NA,"primary breast cancer"
"GSM519420","BRC304","GSM519420","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type II","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 29","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type II","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC304","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519420/suppl/GSM519420.CEL.gz","54627","yes","29","0","0","8.1","female","0","0",NA,"CAF","0","type II","2",NA,NA,"primary breast cancer"
"GSM519421","BRC305","GSM519421","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type III","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC305","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519421/suppl/GSM519421.CEL.gz","54627","no","46","0","0","8.1","female","0","0",NA,"no","0","type III","1",NA,NA,"primary breast cancer"
"GSM519422","BRC306","GSM519422","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 8","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC306","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519422/suppl/GSM519422.CEL.gz","54627","yes","48","0","0","8","female","0","0",NA,"CAF","0","type III","2",NA,NA,"primary breast cancer"
"GSM519423","BRC307","GSM519423","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 64","event_death: 0","follow_up_duration (years): 8","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC307","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519423/suppl/GSM519423.CEL.gz","54627","yes","64","0","0","8","female","0","1",NA,"CAF","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519424","BRC308","GSM519424","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 48","event_death: 0","follow_up_duration (years): 8.4","event_metastasis: 0","subtype: type III","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC308","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519424/suppl/GSM519424.CEL.gz","54627","yes","48","0","0","8.4","female","0","2",NA,"others","0","type III","2",NA,NA,"primary breast cancer"
"GSM519425","BRC309","GSM519425","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 39","event_death: 1","follow_up_duration (years): 3.5","event_metastasis: 1","time_to_metastasis (years): 0","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 1","regional_relapse: 0","adjuvant_chemotherapy: unknown","regimen (caf vs cmf): unknown","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC309","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519425/suppl/GSM519425.CEL.gz","54627","unknown","39","1","1","3.5","female","1","3",NA,"unknown","0","type VI","3","0",NA,"primary breast cancer"
"GSM519426","BRC310","GSM519426","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 40","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type V","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC310","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519426/suppl/GSM519426.CEL.gz","54627","yes","40","0","0","8.1","female","0","0",NA,"CMF","0","type V","1",NA,NA,"primary breast cancer"
"GSM519427","BRC311","GSM519427","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type V","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 55","event_death: 0","follow_up_duration (years): 8.5","event_metastasis: 1","time_to_metastasis (years): 3.7","subtype: type V","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: NA","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC311","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519427/suppl/GSM519427.CEL.gz","54627","yes","55","0","1","8.5","female","0","2",NA,"others","NA","type V","2","3.7",NA,"primary breast cancer"
"GSM519428","BRC312","GSM519428","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 37","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC312","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519428/suppl/GSM519428.CEL.gz","54627","yes","37","0","0","8.1","female","0","1",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519429","BRC313","GSM519429","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 41","event_death: 0","follow_up_duration (years): 6.4","event_metastasis: 1","time_to_metastasis (years): 5.8","subtype: type VI","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC313","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519429/suppl/GSM519429.CEL.gz","54627","yes","41","0","1","6.4","female","0","3",NA,"others","0","type VI","3","5.8",NA,"primary breast cancer"
"GSM519430","BRC314","GSM519430","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 72","event_death: 0","follow_up_duration (years): 1.5","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC314","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519430/suppl/GSM519430.CEL.gz","54627","no","72","0","0","1.5","female","0","2",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519431","BRC315","GSM519431","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 51","event_death: 1","follow_up_duration (years): 6.8","event_metastasis: 1","time_to_metastasis (years): 6.7","subtype: type III","t_stage: 3","n_stage: 2","m_stage: 0","regional_relapse: 1","time_to_relapse (years): 5.6","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC315","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519431/suppl/GSM519431.CEL.gz","54627","yes","51","1","1","6.8","female","0","2",NA,"others","1","type III","3","6.7","5.6","primary breast cancer"
"GSM519432","BRC316","GSM519432","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 59","event_death: 0","follow_up_duration (years): 6.7","event_metastasis: 0","subtype: type IV","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC316","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519432/suppl/GSM519432.CEL.gz","54627","no","59","0","0","6.7","female","0","0",NA,"no","0","type IV","1",NA,NA,"primary breast cancer"
"GSM519433","BRC317","GSM519433","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 6.5","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC317","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519433/suppl/GSM519433.CEL.gz","54627","yes","57","0","0","6.5","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519434","BRC318","GSM519434","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 46","event_death: 1","follow_up_duration (years): 4","event_metastasis: 1","time_to_metastasis (years): 2.1","subtype: type VI","t_stage: 2","n_stage: 2","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CMF","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC318","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519434/suppl/GSM519434.CEL.gz","54627","yes","46","1","1","4","female","0","2",NA,"CMF","0","type VI","2","2.1",NA,"primary breast cancer"
"GSM519435","BRC319","GSM519435","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type IV","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 38","event_death: 0","follow_up_duration (years): 5.8","event_metastasis: 0","subtype: type IV","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC319","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519435/suppl/GSM519435.CEL.gz","54627","yes","38","0","0","5.8","female","0","1",NA,"others","0","type IV","2",NA,NA,"primary breast cancer"
"GSM519436","BRC320","GSM519436","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 56","event_death: 0","follow_up_duration (years): 5","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: no","regimen (caf vs cmf): no","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC320","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519436/suppl/GSM519436.CEL.gz","54627","no","56","0","0","5","female","0","0",NA,"no","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519437","BRC321","GSM519437","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 50","event_death: 0","follow_up_duration (years): 5.3","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC321","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519437/suppl/GSM519437.CEL.gz","54627","yes","50","0","0","5.3","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519438","BRC322","GSM519438","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 49","event_death: 0","follow_up_duration (years): 4.9","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC322","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519438/suppl/GSM519438.CEL.gz","54627","yes","49","0","0","4.9","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519439","BRC323","GSM519439","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type III","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 53","event_death: 0","follow_up_duration (years): 4.7","event_metastasis: 0","subtype: type III","t_stage: 3","n_stage: 3","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): others","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC323","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519439/suppl/GSM519439.CEL.gz","54627","yes","53","0","0","4.7","female","0","3",NA,"others","0","type III","3",NA,NA,"primary breast cancer"
"GSM519440","BRC324","GSM519440","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 44","event_death: 0","follow_up_duration (years): 4.1","event_metastasis: 0","subtype: type VI","t_stage: 1","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC324","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519440/suppl/GSM519440.CEL.gz","54627","yes","44","0","0","4.1","female","0","1",NA,"CAF","0","type VI","1",NA,NA,"primary breast cancer"
"GSM519441","BRC325","GSM519441","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 57","event_death: 0","follow_up_duration (years): 3.8","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 0","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC325","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519441/suppl/GSM519441.CEL.gz","54627","yes","57","0","0","3.8","female","0","0",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519442","BRC326","GSM519442","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 52","event_death: 0","follow_up_duration (years): 3.8","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC326","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519442/suppl/GSM519442.CEL.gz","54627","yes","52","0","0","3.8","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
"GSM519443","BRC327","GSM519443","Public on Apr 24 2011","Mar 08 2010","Jan 19 2016","RNA","1","primary breast cancer tissue, type VI","Homo sapiens","tissue: primary breast cancer","gender: female","age at diagnosis: 34","event_death: 0","follow_up_duration (years): 8.1","event_metastasis: 0","subtype: type VI","t_stage: 2","n_stage: 1","m_stage: 0","regional_relapse: 0","adjuvant_chemotherapy: yes","regimen (caf vs cmf): CAF","","","","Not applicable.","Not applicable.","total RNA","Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and purified with RNeasy Mini Kit (Qiagen, Valencia, CA).","biotin","Biotin-labeled complementary RNA (cRNA) hybridization targets were prepared from 5 ug total RNA by in vitro transcription from cDNA templates according to the Affymetrix protocol. The cRNA was purified and chemically fragmented before hybridization.","9606","A cocktail was prepared by combining the specific amounts of fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA according to the protocol of the manufacturer. The cRNA cocktail was hybridized to oligonucleotide probes on the U133 Plus 2.0 array for 16 hours at 45˚C according to the Affymetrix protocol. Immediately following hybridization, the hybridized probe array underwent an automated washing and staining in an Affymetrix GeneChip Fluidics Station 450 using the protocol EukGE-WS2v5.","U133 Plus 2.0 arrays were scanned using an Affymetrix GeneChip Scanner 3000.","BRC327","The expression intensity of each gene was determined by scaling to a trimmed-mean of 500 using the Affymetrix Microarray Analysis Suite (MAS) 5.0 software. The scaled expression intensities of all human genes on a U133 P2.0 array were logarithmically transformed to the base 2, and normalized using quantile normalization.","GPL570","K.J.,,Kao","Research","Koo Foundation SYS Cancer Center","125 Lih-Der Road, Peitou District","Taipei","Taiwan","112","Taiwan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM519nnn/GSM519443/suppl/GSM519443.CEL.gz","54627","yes","34","0","0","8.1","female","0","1",NA,"CAF","0","type VI","2",NA,NA,"primary breast cancer"
